| Literature DB >> 34800237 |
Florent Noel1, Phan Hoang2, Jennifer Truchot3,4, Anne-Sophie Bard1, Youri Yordanov1,5, Pierre-Clément Thiebaud6.
Abstract
Entities:
Mesh:
Year: 2021 PMID: 34800237 PMCID: PMC8605468 DOI: 10.1007/s11739-021-02896-5
Source DB: PubMed Journal: Intern Emerg Med ISSN: 1828-0447 Impact factor: 5.472
Patients’ characteristics
| Before | After | ||
|---|---|---|---|
| Age, mean (± standard deviation) | 51.7 (± 21.8) | 60.2 (± 21.4) | 0.021* |
| Sex, | |||
| Male | 41 (49) | 29 (47) | 0.755 |
| Female | 42 (51) | 33 (53) | |
| Chief complaint, | |||
| Abdominal pain | 26 (31) | 26 (42) | 0.002* |
| Trauma | 10 (12) | 12 (19) | |
| Thoracic pain | 11 (13) | 1 (2) | |
| Impaired general condition | 5 (6) | 5 (8) | |
| Headache | 8 (10) | 0 | |
| Neurological deficit | 5 (6) | 0 | |
| Othersa | 18 (22) | 18 (29) | |
| Mean reason for a PIVI order, | |||
| Life-threatening emergency | 0 | 0 | < 0.001* |
| Volume expansion or hydration | 13 (16) | 38 (61) | |
| To keep vein open | 47 (57) | 1 (2) | |
| Exclusive intravenous drug | 7 (8) | 8 (13) | |
| Impossible oral administration | 8 (10) | 5 (8) | |
| Not-by-mouth status | 8 (10) | 10 (16) | |
| Intravenous drug, | |||
| Yes | 52 (63) | 50 (81) | 0.019* |
| No | 31 (37) | 12 (19) | |
| Blood sample, | |||
| Yes | 77 (93) | 60 (97) | 0.467 |
| No | 6 (7) | 2 (3) | |
| Imaging with contrast agent, | |||
| Yes | 23 (28) | 14 (23) | 0.483 |
| No | 60 (72) | 48 (77) | |
| Visit outcome, | |||
| Hospitalization | 41 (49) | 36 (58) | 0.301 |
| Discharged | 42 (51) | 26 (42) | |
*Statistically significant (p < 0.05)
aComplaints with frequency < 5%
Unjustified PIVI orders
| Before | After | ||
|---|---|---|---|
| Evaluator n°1, | 46 (56) | 22 (36) | 0.017* |
| Evaluator n°2, | 34 (41) | 11 (18) | 0.003* |
| Evaluator n°3, | 53 (64) | 28 (45) | 0.025* |
| Majority, | 43 (52) | 16 (26) | 0.002* |
| Unanimity, | 27 (33) | 8 (13) | 0.006* |
Statistically significant (p < 0.05)